Adimmune Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,793	2,186	2,345	2,458	2,857	2,652
Short-Term Investments	52.01	31	112.5	12.5	100.5	239
Trading Asset Securities	-	0.47	-	-	-	-
Cash & Short-Term Investments	1,845	2,218	2,457	2,470	2,958	2,891
Cash Growth	-13.85%	-9.73%	-0.52%	-16.49%	2.30%	-34.66%
Accounts Receivable	137.95	146.86	187.81	1,308	534.97	99.64
Other Receivables	-	38.63	39.76	30.51	43.09	111.22
Receivables	137.95	185.5	227.57	1,339	578.06	210.86
Inventory	592.85	692.91	764.59	682.33	815.94	602.1
Prepaid Expenses	230.93	6.44	6.45	8.19	4.42	4
Other Current Assets	106.5	168.31	154.27	200.21	135.34	88.02
Total Current Assets	2,913	3,271	3,610	4,699	4,491	3,796
Property, Plant & Equipment	4,045	4,015	3,818	3,613	3,641	3,447
Long-Term Investments	110.11	91.64	109.66	105.86	100.25	119.34
Other Intangible Assets	21.05	17.9	34.46	51.11	67.98	85.82
Long-Term Accounts Receivable	334.93	334.93	334.93	334.93	326.66	137.37
Long-Term Deferred Tax Assets	227.26	227.26	227.42	227.6	227.59	228.03
Long-Term Deferred Charges	-	7.45	13.4	19.36	25.32	31.27
Other Long-Term Assets	169.46	227.8	333.93	433.57	268.29	165.53
Total Assets	7,821	8,193	8,481	9,484	9,149	8,010
Accounts Payable	30.74	17.04	31.25	42.35	48.84	5.88
Accrued Expenses	-	198.41	195.15	126.85	192.83	145.77
Short-Term Debt	222.5	325	500	540	20	-
Current Portion of Long-Term Debt	890.8	890.8	320.04	669.93	125.01	41.09
Current Portion of Leases	22.87	20.62	19.02	14.71	16.68	7.13
Current Unearned Revenue	20.63	35.45	9.39	21.81	11.11	23.44
Other Current Liabilities	197.61	58.53	86.46	371.3	86.02	73.73
Total Current Liabilities	1,385	1,546	1,161	1,787	500.49	297.04
Long-Term Debt	1,545	1,548	1,705	1,869	2,039	1,266
Long-Term Leases	40.97	45.91	52.33	48.71	61.65	6.34
Other Long-Term Liabilities	1.66	1.25	0.84	1.94	2.35	7.95
Total Liabilities	2,973	3,141	2,920	3,707	2,604	1,578
Common Stock	4,295	4,295	4,295	4,295	4,295	4,295
Additional Paid-In Capital	829.5	829.5	829.5	835.41	849.05	855.12
Retained Earnings	-99.43	86.12	351.19	597.61	1,238	944.84
Treasury Stock	-292.54	-292.54	-292.54	-292.54	-292.54	-
Comprehensive Income & Other	23.06	26.24	49.49	38.94	34.62	53.79
Total Common Equity	4,756	4,944	5,233	5,475	6,124	6,149
Minority Interest	92.32	107.32	328.97	303.07	421.07	283.72
Shareholders' Equity	4,848	5,052	5,562	5,778	6,545	6,433
Total Liabilities & Equity	7,821	8,193	8,481	9,484	9,149	8,010
Total Debt	2,723	2,830	2,597	3,143	2,263	1,321
Net Cash (Debt)	-877.83	-612.29	-139.56	-672.63	695.03	1,570
Net Cash Growth	-	-	-	-	-55.74%	-49.36%
Net Cash Per Share	-2.08	-1.45	-0.33	-1.60	1.63	3.66
Filing Date Shares Outstanding	421.69	421.51	421.51	421.51	421.51	429.51
Total Common Shares Outstanding	421.69	421.51	421.51	421.51	421.51	429.51
Working Capital	1,528	1,725	2,449	2,912	3,991	3,499
Book Value Per Share	11.28	11.73	12.41	12.99	14.53	14.32
Tangible Book Value	4,735	4,926	5,198	5,423	6,056	6,063
Tangible Book Value Per Share	11.23	11.69	12.33	12.87	14.37	14.12
Land	-	14.36	14.36	14.36	14.36	14.36
Buildings	-	2,148	2,143	2,138	2,117	2,108
Machinery	-	2,319	2,319	2,332	2,255	1,999
Construction In Progress	-	1,718	1,379	1,029	1,100	1,032